Concord Medical Services (CCM) Stock Price, News & Analysis

Company Overview

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Key Stats

• Today's Range: $3.88 to $4.31
• 50-Day Range: $3.93 to $5.31
• 52-Week Range: $3.80 to $26.70
• Volume: 98,733 shs
• Average Volume: 19,879 shs
• Market Capitalization: $18.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CCM Stock Analysis - Frequently Asked Questions

How have CCM shares performed this year?

Concord Medical Services' stock was trading at $5.38 at the beginning of 2025. Since then, CCM shares have decreased by 21.6% and is now trading at $4.22.
View the best growth stocks for 2025 here.

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Holdings Limited (NYSE:CCM) released its quarterly earnings data on Wednesday, August, 24th. The company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.10 by $2.70. The business had revenue of $18.93 million for the quarter.

When did Concord Medical Services' stock split?

Shares of Concord Medical Services reverse split on the morning of Tuesday, July 30th 2024. The 1-10 reverse split was announced on Tuesday, July 30th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Concord Medical Services?

Shares of CCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concord Medical Services investors own include M&T Bank (MTB), The Carlyle Group (CG), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD), Catalyst Biosciences (CBIO) and Chevron (CVX).

Company Calendar

• Last Earnings: 8/24/2016
• Today: 4/14/2025
• Next Earnings (Estimated): 4/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Offices & clinics of medical doctors
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CCM
• CIK: 1472072
• Web: www.concordmedical.com
• Phone: 861059036688
• Fax: 86-10-5957-5252
• Employees: 970
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.15
• Current Ratio: 0.47
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: $471.70 million
• Price / Sales: 0.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $56.67 per share
• Price / Book: 0.07

Miscellaneous

• Outstanding Shares: 4,342,000
• Free Float: 2,323,000
• Market Cap: $18.32 million
• Optionable: Not Optionable
• Beta: -0.64